Emerging Anti-cancer Compounds and Immunomodulators for Pancreatic Cancer Treatment
Author | : Stephen Safe |
Publisher | : Frontiers Media SA |
Total Pages | : 103 |
Release | : 2024-04-29 |
ISBN-10 | : 9782832548486 |
ISBN-13 | : 2832548482 |
Rating | : 4/5 (86 Downloads) |
Book excerpt: Pancreatic cancer is a highly lethal gastrointestinal disease that is becoming one of the leading causes of cancer mortality worldwide. Despite advances in surgery, radiation therapy, immuno-oncology, and therapeutics, the 5-year survival rate for pancreatic cancer patients remains around 12%. The poor prognosis is mainly due to late diagnosis, as pancreatic cancer patients commonly don’t exhibit symptoms until an advanced stage that is beyond surgical resection. Currently, the main treatments for patients with advanced pancreatic cancer are chemotherapy, radiotherapy, and most recent clinical trials incorporate immunotherapy.